The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

$440 million payback due to tainted research

This article appears courtesy of Institutional Investor

A federal judge in New York City has given the green light to the Securities and Exchange Commission, the NASD and the New York Stock Exchange to distribute an estimated $440 million to some 15,000 of 20,000 investors who were determined to be harmed by tainted research. The checks, which are expected to be mailed before the end of the year, reports The New York Times, range from $100 to $15 million, which are said to be claims paid in full.

About half the 20,000 claims that are part of the $1.4 billion settlement that a 11 banks agreed to pay, belong to investors who held 100 or few shares. Merrill Lynch, which settled separately, is not part of this fund.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree